The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Avelox 400 mg film-coated tablets

400 milligram(s) Film-coated tablet

PCO Manufacturing Ltd.PPA0465/230/001

Main Information

Trade NameAvelox 400 mg film-coated tablets
Active SubstancesMoxifloxacin hydrochloride
Strength400 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/230/001

Group Information

ATC CodeJ01MA Fluoroquinolones
J01MA14 moxifloxacin


Licence Issued24/07/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA1410/027/001.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back